Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "markets"

1471 News Found

Hoola Health raises $5 million to expand child-centric paediatric care
Startup | June 10, 2026

Hoola Health raises $5 million to expand child-centric paediatric care

Bengaluru-based startup will use the fresh capital to enter new markets, enhance technology capabilities, and scale its integrated care model


Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore
News | June 10, 2026

Viyash Scientific to acquire Italy’s BioForLife for Rs. 188 crore

The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe


Ajanta Pharma elevates Atul Galgalikar as Vice President for international business
People | June 10, 2026

Ajanta Pharma elevates Atul Galgalikar as Vice President for international business

Pharma industry veteran brings more than two decades of experience in sales, marketing, business development, and global market expansion to his new leadership role


Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce
Policy | June 10, 2026

Pharma industry poised to reach US$ 130 billion by 2030: Joint Secretary, Department of Commerce

Mohit Yadav reaffirmed government's commitment to improve competitiveness, enhance export capabilities and support the country's transition from volume-driven to value-driven exports


Lupin partners with LABORATORIOS ERN to launch Luforbec in Spain
News | June 09, 2026

Lupin partners with LABORATORIOS ERN to launch Luforbec in Spain

Collaboration combines Lupin’s inhaler manufacturing capabilities with ERN’s strong commercial presence to expand access to respiratory care


AstraZeneca reports major Phase III breakthrough in IgA kidney disease trial
Clinical Trials | June 09, 2026

AstraZeneca reports major Phase III breakthrough in IgA kidney disease trial

At 34 weeks, Ultomiris achieved a 43.4% placebo-adjusted reduction in 24-hour urine protein creatinine ratio (UPCR) versus placebo, meeting the study’s key interim endpoint


Punita Kumar-Sinha appointed Independent Director at Aurobindo Pharma USA
People | June 09, 2026

Punita Kumar-Sinha appointed Independent Director at Aurobindo Pharma USA

Seasoned governance expert and board leader brings extensive experience in strategic oversight, risk management, and corporate governance across multiple sectors


Medtronic secures CE Mark for Stealth AXiS surgical navigation system in Europe
Medical Device | June 09, 2026

Medtronic secures CE Mark for Stealth AXiS surgical navigation system in Europe

New-generation platform enhances anatomical visualization, streamlines surgical workflows, and expands access to advanced navigation technology for ENT surgeons across Europe


Lupin Manufacturing Solutions appoints Eduardo Jule as Chief Commercial Officer
News | June 08, 2026

Lupin Manufacturing Solutions appoints Eduardo Jule as Chief Commercial Officer

Veteran pharma and biotech executive brings over 20 years of commercial leadership experience to support LMS's global CDMO and API growth strategy


Everest Medicines expands Asia-Pacific presence with licensing deal for Bejescin
News | June 08, 2026

Everest Medicines expands Asia-Pacific presence with licensing deal for Bejescin

Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio